MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%

Sector Heatmap

Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%

PTCT — PTC Therapeutics, Inc.

Nasdaq

PTC Therapeutics, Inc.

CompareBack to Screener
$63.23
-0.47(-0.74%)
O
63.19
H
64.04
L
62.84
V
1.04M
⏱️ End-of-day dataAs of Oct 7, 2026

Chart

About PTCT

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJun 20, 2013
Employees991
Stock ExchangeNasdaq
Ticker SymbolPTCT

Key Financial Statistics

Market Cap$5.30B
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$61.23 - $90.87
52-Week Avg Volume1.41M
VWAP$63.41
Transactions17,452
Total Recorded Bars3,345 days